Beta Bionics Inc. was born out of a father’s desire to improve his son’s quality of life following a diabetes diagnosis. Today, 10 years after its founding, it’s now a publicly traded company. The ...
IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary, ...
Today, the Washington Post reports that a new life is within reach for the first woman with bionic arm (free registration required). Claudia Mitchell lost an arm in a motorcycle accident, but she's ...
Beta Bionics, Inc., a leader in diabetes management solutions, announced it will release its first quarter financial results for 2025 on May 6, 2025, after market close. Management will hold a ...
TipRanks on MSN
Beta Bionics price target raised to $33 from $30 at BofA
BofA analyst Travis Steed raised the firm’s price target on Beta Bionics (BBNX) to $33 from $30 and keeps a Buy rating on the shares as the firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback